Article
Effects of <i>NT5C2</i> germline variants on 6-mecaptopurine metabolism in children with acute lymphoblastic leukemia
2020-10-14
Abstract excerpt
6-mercaptopurine (6-MP) is widely used in the treatment of acute lymphoblastic leukemia (ALL), and its cytotoxicity is primarily mediated by thioguanine nucleotide metabolites (TGN). Recent genome-wide association study has identified germline polymorphisms (e.g., rs72846714) in the NT5C2 gene associated with 6-MP metabolism in patients with ALL. However, the full spectrum of genetic variation in NT5C2 is unclea...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 06109353-b137-59c2-b753-33f9115ee2f5
- DOI
- 10.1101/2020.10.13.338384
